T Naftali-Timna

59 Tshernichovsky St
Kfar Saba, M 95847, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Safety and Preliminary Clinical Outcomes of a Combined Cannabidiol and Sodium Propionate Enema in Refractory Ulcerative Proctitis: An Open-Label Pilot Study.

Safety and Preliminary Clinical Outcomes of a Combined Cannabidiol and Sodium Propionate Enema in Refractory Ulcerative Proctitis: An Open-Label Pilot Study.

Journal: Inflammatory intestinal diseases

Published: April 03, 2026

Tasty&Healthy Whole-Food Diet in Asymptomatic Children and Young Adults With Biologically Active Crohn's Disease: The TASTI-E Randomized Controlled Trial.

Tasty&Healthy Whole-Food Diet in Asymptomatic Children and Young Adults With Biologically Active Crohn's Disease: The TASTI-E Randomized Controlled Trial.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 17, 2025

A novel enema formulation containing cannabidiol and sodium propionate for ulcerative colitis: preclinical assessment in a murine model.

A novel enema formulation containing cannabidiol and sodium propionate for ulcerative colitis: preclinical assessment in a murine model.

Journal: Journal of cannabis research

Published: July 17, 2025

Association Between Ethnicity and Treatment Preferences in Patients with Irritable Bowel Syndrome.

Association Between Ethnicity and Treatment Preferences in Patients with Irritable Bowel Syndrome.

Journal: Rambam Maimonides medical journal

Published: April 30, 2025

Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled Trial.

Capsule Endoscopy-Guided Proactive Treat-to-Target Versus Continued Standard Care in Patients With Quiescent Crohn's Disease: A Randomized Controlled Trial.

Journal: Gastroenterology

Published: November 07, 2024

Upper and Lower Endoscopic Findings in Mesenteric Panniculitis Patients: A Case-Control Study.

Upper and Lower Endoscopic Findings in Mesenteric Panniculitis Patients: A Case-Control Study.

Journal: Journal of clinical medicine

Published: September 08, 2024

Effects of the Transcutaneous Electrical Stimulation System on Heartburn, Regurgitation and Esophageal Acid Exposure in GERD Patients-An Uncontrolled Feasibility Study.

Effects of the Transcutaneous Electrical Stimulation System on Heartburn, Regurgitation and Esophageal Acid Exposure in GERD Patients-An Uncontrolled Feasibility Study.

Journal: Neurogastroenterology and motility

Published: August 17, 2024

Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.

Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.

Journal: Journal of Crohn's & colitis

Published: July 11, 2023

Upadacitinib for Acute Severe Ulcerative Colitis.

Upadacitinib for Acute Severe Ulcerative Colitis.

Journal: Inflammatory bowel diseases

Published: July 04, 2023

Cannabis Improves Clinical Outcomes and Quality of Life in Patients With Chronic Pouchitis.

Cannabis Improves Clinical Outcomes and Quality of Life in Patients With Chronic Pouchitis.

Journal: ACG case reports journal

Published: May 15, 2023

Mesenchymal stem cell therapy for Crohn's perianal fistula-a real-world experience.

Mesenchymal stem cell therapy for Crohn's perianal fistula-a real-world experience.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: October 14, 2022

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study.

Journal: Journal of Crohn's & colitis

Published: July 27, 2022

Showing 1-12 of 71

Last Updated: 09/26/2026